A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.

NCT04573556 · clinicaltrials.gov ↗

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: Lemborexant

Sponsor

Eisai Co., Ltd.